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A recent Cochrane Review addressing behavioral and/or cognitive pain 
management techniques for healthy infants older than one month demonstrated that not 
one technique had sufficient evidence for procedural pain [15,16]. In addition, the vast 
majority of parents do not use pharmacological strategies for acute procedural pain in 
infancy [13,23], despite demonstrated efficacy, suggesting infant acute pain management 
is cause for concern.  
These findings subsume an important need for a greater quantity of research on 
healthy infants’ pain management over the first year of life. In developed nations, infancy 
is the time when most infants receive the most immunization needles [17]. Needle 
phobias, healthcare avoidance, and increased pain reactivity are all implications of these 
experiences documented in the literature [22,25,26]. In addition, compared to infancy, no 
other period of development results in greater biological, psychological, and social 
change suggesting greater implications of unrelieved pain during this formative period 
[14]. This steep development is often ignored in treatment studies exploring pain 
management by coarsely grouping infants of different ages [4-7].  
Infant development researchers have long recognized the crucial influence of age 
and individual differences (such as temperamental predispositions to negative affect 
reactivity/regulation) on infants’ reactions [3,19]. Infant pain researchers are just 
beginning to investigate the idea that pain reactions post-procedure may also be a 
function of temperamental predispositions and not simply the painful stimulus [8,10]. If 
pain reactions are due, in part, to reliable individual differences (such as stable patterns in 
how certain infant react or regulate from noxious stimuli), using a simple overall mean 
score (i.e. averaged over all infants within a sample or treatment arm) may pose a serious 
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conceptual flaw when conducting research involving infant pain management, as the 
efficacy of pharmacological and non-pharmacological strategies may vary along the 
continuum of such individual differences.  
Taking a step in this direction, this study examined a longitudinal cohort of 
healthy infants followed over immunizations during the first year of life. The purpose 
was to determine if individual differences regarding infants’ pain responses post-needle 
(pattern of pain scores from immediately post-needle to 2 minutes post needle) can be 
effectively discerned. After the groups are discerned, mean pain scores were calculated 
for each group separately and then each mean pain score was compared to the overall 
mean pain score (i.e. collapsed over groups) to determine if any of the groups differ from 
their respective overall mean in a clinically significant manner. First, we hypothesized 
that there will be sufficient heterogeneity in pain responses to describe individual 
differences using distinct groups. Second, we hypothesized that these reliably discerned 
groups will have clinically meaningful differences in pain responding when compared to 
the overall mean.  
 
METHODS 
Study Cohort 
The data collection procedures and measures are described in detail elsewhere 
[1,14,18], with only a synopsis below. Ethical approval was obtained through research 
ethics review boards at both the participating university and the associated pediatric 
hospital. 
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  The data are part of our ongoing longitudinal study in which caregiver-infant 
dyads are recruited from three pediatric clinics in the greater Toronto area and followed 
in a cohort sequential design during immunizations over the first 12 months of child’s life 
and again at the preschool immunization. Data were collected between October 2007 and 
May 2012. Infants were recruited at 2-, 4- or 6-months of age. The withdrawal rate for 
the infant waves was 3%. The sample included data from 747 different infants. Based on 
the analysis plan, a given infant’s data were included in analyses if the infant was 
observed at any time point (2-month n = 485; 4-month n = 574, 6-month n = 568 and 12-
month n = 458). See Table 1 for demographic characteristics. The infants are healthy, 
from middle class families, low-risk, and developmentally typical. Caregivers were fluent 
in English and legal guardians of the studied infant.  
Procedure 
During each immunization appointment, infants’ facial, vocal, and body 
movements were video recorded before and after the immunization. Parents filled in a 
short demographic questionnaire prior to each immunization appointment. First, infants 
were observed at different times over a single immunization appointment (immediately 
after final needle, 1-minute after the final needle, 2-minutes after the final needle) and 
second, they were observed at subsequent appointments through the first year of life. This 
is a naturalistic observational study: Families were observed during their infant 
immunization appointments with little interference on the part of the research team, aside 
from the videotaping of the procedure.  
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Behavioral Coding Measures 
The Modified Behavior Pain Scale (MBPS) [24] was used to assess the degree of 
infant pain-related distress. Coders rated the severity of distress reflected in three types of 
infant pain behaviours (facial expression, cry, and body movement) during three different 
15-second epochs [15-seconds immediately after the needle (MBPS0), one minute after 
the needle (MBPS1), and two minutes after the needle (MBPS2)]. For each epoch, all 
three behaviours were summed to calculate a pain score out of ten (higher scores reflect 
higher pain). MBPS0 reflects the peak pain response that occurs right after the needle. A 
lowering of scores from MBPS0 to MBPS1 to MBPS2 would represent regulation from 
the peak distress (i.e. a returning to baseline or pre-needle levels of pain). Moderate to 
high concurrent and construct validity as well as item-total and inter-rater reliability have 
all been demonstrated in the immunization context [24]. Our primary coders were blinded 
to the study hypotheses and interrater reliability was high (intraclass correlations ranging 
from .93 to .96).  
After the groups were discerned statistically (primary analysis), to understand if 
any of the group means on the MBPS at any of the epochs or ages differed notably from 
the overall mean (i.e. pain scores collapsed over groups at each of the ages and/or 
epochs), clinical significance on the MBPS was considered (secondary analysis). Only 
differences greater than 1 point on the 10-point MBPS were considered clinically 
significant. This is in line with recently published meta-analytic work determining the 
effect of a known analgesic agent on immunization pain using MBPS [21]. 
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Statistical Analysis 
To address our two research questions, two types of analyses were conducted.  
First, growth mixture modeling (GMM) is a technique used to summarize individual 
variation on a set of longitudinal repeated measures (i.e., trajectories) using a small 
number of homogeneous subgroups within a sample [12]. We were interested in growth 
mixtures of pain responses both across age and within age across the first two minutes 
post immunization. First, to model heterogeneity in immediate infant pain reactivity post-
needle across age, we examined MBPS0 across 2, 4, 6 and 12 months of age (one GMM 
model). Second, to model heterogeneity in how infants regulate from peak distress, we 
examined the trajectory of scores from MBPS0 to MBPS1 to MBPS2 separately within 
each of the four age groups (4 GMM models). In a GMM, infants are not assigned to 
groups deterministically; instead, each participant receives a score that represents the 
probability that she or he would be assigned to each of the discerned groups. Thus, for 
our secondary analyses, when reporting group means for any of the individual groups, 
only infants that had a probability of .9 or greater of belonging to one of the groups were 
used. For each GMM, we provide the proportion of infants that had a class probability 
score greater than .9.  Only these infants were used to calculate the group means to be 
described below. At all ages, this encompassed the vast majority of infants. 
For each of the models, we first specified a single group and then tested a series 
of models formed by increasing the number of groups. Models with varying numbers of 
groups were compared using Akaike’s Information Criterion (AIC) [2] and the Bayesian 
Information Criterion (BIC) [20]. Smaller values of AIC and BIC are associated with 
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improved model fit. We systematically increased the number of groups until these model 
fit measures no longer justified the extraction of additional groups (or had obtained an 
improper model with a negative residual variance term). For brevity, AIC and BIC 
statistics will only be provided for the penultimate model and the final model. Although 
all groups will be shown on the graph for each GMM because they are a part of the best 
fitting solution, we will not discuss groups that contained less than 5% of the sample 
because they are unlikely to replicate in future studies [9].  
 After the groups were discerned for each of the 5 models, for the secondary 
analyses, group means from each model (i.e. the mean of each group at a particular epoch 
and/or age) were compared to the overall mean (i.e. the mean of the entire sample at the 
corresponding epoch and/or age, collapsed over the discerned groups). Table 2 provides 
the group and overall means for the ‘immediate pain reactivity over ages’ model or 
Model 1. Table 3 provides the group and overall means for each of the 12 age by epoch 
combinations (Models 2-5).  
For the sake of completeness at each age (2-, 4-, 6- and 12-months) and epoch 
combination (MBPS0, MBPS1, MBPS2), ANOVAs were formally used to test 
differences among the group means. Results of these ANOVAs and post-hoc tests are in 
Table 2 and 3, but they are not discussed because they are secondary to the purpose of 
determining if the group means have clinically meaningful differences (i.e. larger than 1 
MBPS point) from the respective overall mean that would have been calculated from the 
whole sample in the traditional approach to infant pain measurement.   Given our sample 
size, the criterion of clinical significance was considered more stringent than statistical 
significance. 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 
8 
 
 
RESULTS 
 Model 1: Immediate Pain Reactivity Across Ages 
The two-group model was an improvement over the one-group model (AIC = 
5782.12 vs. 9809.09, BIC = 5851.37 vs. 9850.64; see Figure 1). Both groups had high 
immediate pain reactivity at 2, 4 and 6 months. At the 12-month immunization, Group 1 
(6.3% of the sample) had a much lower immediate pain reaction (about almost half the 
magnitude of earlier ages) while Group 2 (93.7% of the sample) continued to demonstrate 
a high immediate pain reaction at 12-months. In this model, 94.51% of the sample had a 
probability of .9 or higher for belonging to one of the groups.  
Secondary analyses demonstrated that, except for the 12-month immediate pain 
reactivity mean score of Group 1, which was underestimated by the 12-month immediate 
pain reactivity overall mean by 4.38 MBPS points (0-10 scale), the overall mean at every 
age did not meaningfully differ from the individual group means at every age (See Table 
2 for mean values).  
Model 2: Pain Regulation Trajectories at 2 Months 
The three-group model was an improvement over the two-group model (AIC = 
4532.59 vs. 4686.38, BIC = 4607.91 vs. 4744.96; see Figure 2). The third group is not 
described due to low prevalence (0.8% of the sample). Groups 1 and 2 had similar 
regulatory trajectories whereby both groups had a severe pain response right after the 
needle and then regulated slightly by the first minute post-needle but did not regulate any 
further at 2 minutes post-needle. The main difference between the groups was that Group 
1 (17.7% of the sample) was about 1 MBPS point lower at each time point than Group 2 
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(81.5% of the sample). In this model, 100% of the participants had a probability of .9 or 
higher for belonging to one of the groups.  
The secondary analyses demonstrated that except for Group 1’s mean pain score 
at 1-minute post needle, which was overestimated by the 2-month overall mean at 1-
minute post-needle by 1.13 MBPS points (0-10 scale), the overall mean at every 2-month 
epoch did not differ from the individual group means (at every epoch) at clinically 
meaningful levels (See Table 3).  
Model 3: Pain Regulation Trajectories at 4 Months 
The four-group model was an improvement over the three-group model (AIC = 
6534.00 vs. 6569.27, BIC = 6629.84 vs. 6647.68; see Figure 3). The second group is not 
described due to low prevalence (1.8% of the sample). Group 1 (9.3%) showed a 
moderate pain response immediately post-needle and then regulated to low levels of 
distress by 1 minute post-needle and stayed regulated at 2 minutes post-needle. Groups 3 
(36.9%) and 4 (52%) both showed severe pain responses initially and regulated to 
moderate pain levels by 1 minute. These latter groups differed most at 2 minutes post-
needle in that Group 3 continued to regulate a little more but infants in Group 4 had their 
pain-related distress increase slightly.  95.60% of the participants had a probability of .9 
or higher for belonging to one of the groups.  
Group 1’s mean pain score at all three post-needle epochs i.e. immediately, 1-
minute and 2-minute, was overestimated by the corresponding overall means at each 
epoch (1.66, 2.4 and 1.7 MBPS points, respectively) in secondary analyses. The overall 
means (for every epoch) did not differ from the individual group means at clinically 
meaningful levels for Group 3 and 4 (See Table 3). 
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Model 4: Pain Regulation Trajectories at 6 Months 
The three-group model was an improvement over the two-group model (AIC = 
5943.89 vs. 6176.56, BIC = 6022.05 vs. 6237.34; see Figure 4). Group 1 (52% of the 
sample) had a severe pain response, regulated substantially to moderately low pain levels 
by 1 minute and even lower pain levels by 2 minutes. Group 2 (42.4%) showed a severe 
pain response right after the injection, regulated to slightly lower pain levels at 1 minute, 
and stayed at this level at 2 minutes. Group 3 (5%) had a moderate pain response right 
after the needle, regulated to low pain scores by 1 minute, and then regulated even more 
by 2 minutes. 85.2% of the participants had a probability of .9 or higher for belonging to 
one of the groups. 
In terms of the secondary analyses, for Group 1, the overall means at each epoch 
only had a clinically meaningful difference at the 2-minute epoch (overestimating by 2.07 
MBPS points). For Group 2, the overall mean at each epoch had a clinically significant 
difference at the 1-minute and 2-minute epochs (underestimating by 1.23 and 2.91 MBPS 
points respectively). For Group 3, clinically meaningful differences with the overall mean 
were seen at all three post-needle epochs (overestimating by 4.34, 2.67 and 2.11 MBPS 
points, respectively; See Table 3). 
Model 5: Pain Regulation Trajectories at 12 Months 
The six-group model was an improvement over the five-group model (AIC = 
4621.47 vs. 4638.76, BIC = 4638.76 vs. 4746.06; see Figure 5). Group 1 (6.1% of the 
sample) started with a moderate pain response, regulated to low pain levels by 1 minute, 
and stayed at low levels at 2 minutes. Group 2 (39.4%) expressed a severe initial pain 
response that stayed high at 1 and 2 minutes post-needle. Group 3 (20.1%) had a severe 
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pain response initially with minimal regulation at 1 minute and then significant regulation 
to low pain levels by 2 minutes after the needle. Group 4 (20.6%) started with a severe 
pain response, regulated to low pain levels by 1 minute, and stayed regulated at 2 
minutes. Similarly, Group 5 (5.8%) started with a severe pain response and regulated 
substantially by 1 minute; however, at 2 minutes a severe pain response recurred. Finally, 
Group 6 (7.9%) showed a severe pain response immediately after the needle, regulated to 
moderate pain levels at 1 minute, and stayed at that level at 2 minutes.  74% of the 
participants had a probability of .9 or higher of being placed in one of the groups.  
The secondary analyses demonstrated that the immediate pain reactivity epoch, 
the mean for each of the groups was well-represented by the overall mean, except in the 
case of Group 1 (overall mean for the epoch overestimated the group mean by 4.38 
MBPS points). During the other epochs (1 and 2 minutes post-needle), almost every 
group had clinically meaningful differences with the overall mean for the respective 
epoch (ranging from overestimates of 3.46 to underestimates of 2.72). The one exception 
was that Group 6’s mean pain score at 2-minutes post-needle was in line with the overall 
mean for that epoch. See Table 3. 
DISCUSSION 
To our knowledge, this is the largest longitudinal cohort studied to date 
addressing the issue of variability in infant pain response. With almost 750 infants 
studied, we were able to conduct analyses never previously attempted on pain scores 
reflective of immediate reactivity and pain scores during the regulatory or recovery 
phases post-procedure. Stable groups were discerned at each of the four ages 
demonstrating that there were groups of infants that substantially differed in their patterns 
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of pain responding over the 2-minutes post-needle. Using these discerned groups, our 
secondary analyses demonstrated that at almost every age and/or epoch between-group 
analysis, significant differences were evident. Thus, putting the results together, as the 
infants aged (despite the same context, similar pain stimulus, and increasing familiarity 
with the doctor’s office paradigm for both parent and child), there was increasing inter-
group variation that resulted in clinically significant differences when comparing the 
discerned groups to an overall mean.  This suggests increasing concern for the validity of 
using overall group means without some attention to the potential for trait-like 
differences in negative affect regulation, distress, or pain responding. Our discussion 
focuses on clinically meaningful differences with the overall means for each age and/or 
epoch combination. In the following commentary, severe pain was considered in the 7 to 
10 range on the MBPS scale, moderate pain in the 5 to 6 range, and scores in the 0 to 4 
range were mild to no pain [11].   
Immediate Post-needle Pain Reactivity Across the First Year of Life.    
Two trajectory groups were sufficient to characterize variation in the immediate 
post-needle pain response of infants across 2, 4, 6, and 12 months of age. The overall 
mean pain reactivity represented these groups very well at 2, 4, and 6 months. But at 12 
months, the overall mean substantially overestimated the group that had a moderate to 
low average pain response right after the needle (only 6% of the sample).   Overall, it was 
the findings from this analysis that imply that there is little variability between groups of 
infants in immediate response to the needle over the first year of life.  Generally 
speaking, most infants’ pain scores were in the severe pain range directly following the 
needle, regardless of their age.  This suggests that using a mean pain score, averaged over 
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all infants within a given sample or treatment arm, in the fifteen-seconds immediately 
following an acutely painful stimulus, appears to be well justified in terms of 
homogeneity of intensity level.   
Pain Responding at 2 Months 
When examining the pain responses of the infants at two months, two 
significantly different patterns (based on how they regulated post-needle were discerned). 
The group trajectories were similar whereby they mounted a severe pain response post-
needle and had moderate regulation (lowering of pain-related distress), except one group 
(18%) was about 1 to 1.5 MBPS points lower at each time point. Accordingly secondary 
analyses indicated that, while the overall means at needle, 1 minute, and 2 minutes 
represented the majority of the sample well, it overestimated the one group by about 1 
point at every measurement. It is noteworthy that neither group regulated to below 4 
MBPS points within the 2 minutes post-needle suggesting moderate to severe pain for the 
entire 2-minute post needle period for all infants. 
Pain Responding at 4 Months  
At 4 months of age, there were three discernible patterns of pain responding over 
the two minutes post immunization. Two of the groups made up about 90% of the sample 
and both displayed a severe pain response after the needle, regulated to moderate pain, 
and stayed at that level (one of these group was about .7 of a MBPS point lower than the 
other at all time points). The third group showed a moderate pain response immediately 
after the needle and then regulated to a mild level by 2 minutes. This group was about 1.5 
to 2.5 points less than the other two groups at every time point. Secondary analyses 
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suggested that the overall mean represented the two large groups quite well, but 
overestimated the remaining 10% of the sample at every time point. 
Generally speaking, with the younger infants (2 or 4 months), the overall mean 
did a good job estimating the pain level of almost the whole sample (90-100%) at post-
needle, 1 minute post-needle and 2 minutes post-needle.  There was some variability 
between the groups and, although significant statistically, when compared to the overall 
mean, neither of the larger groups were clinically different in a  significant manner. This 
pattern changed dramatically with the older infants. 
Pain Responding at 6 Months 
As suggested, while the analyses for 6 month olds also had three groups 
discerned, the groups had very different regulatory trajectories from each other. The first 
group (52% of the sample) had a severe pain response, regulated to low to moderate pain 
by 1 minute, and then to even lower pain levels by 2 minutes. The second group (42% of 
the sample) showed a severe pain response, regulated slightly to a moderate level of pain, 
and then dysregulated slightly to higher level of pain. The third group, 5% of the sample, 
showed a moderate pain response, regulated to mild pain levels by 1 minute, and stayed 
regulated at 2 minutes. When doing comparisons during the secondary analyses, it was 
found that the overall mean adequately represented the first and second groups 
immediately post-needle and the first group at 1 minute, but it did not represent any 
group well at 2 minutes. Thus, at the immediate post-needle epoch, 5% of the sample was 
severely overestimated by the overall mean (by 4 MBPS points), at 1 minute 42% of the 
sample was underestimated and 5% were overestimated, and by 2 minutes 100% of 
sample was either over or underestimated within the range of 2 to 3 MBPS points.  It 
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appears that there was a marked change in the variability of infant pain responding at the 
6 month mark, likely reflecting developmental maturity such that more stable individual 
difference in pain responding is more evident.  
Pain responding at 12 Months 
Furthering this speculation, at 12 months, 6 groups were discerned, all with very 
different regulatory patterns. In terms of the three largest groups (each capturing 20% to 
40% of the sample), all three had a severe pain response initially, then one group 
regulated only slightly over the 2 minutes, one group regulated slightly at 1 minute but 
then fully regulated to mild pain by 2 minutes, and the last group regulated completely by 
1 minute and stayed regulated. Among the three smaller groups (each 6 to 7% of the 
sample), one group showed a low to moderate initial response and regulated stably by 1 
minute. The other two groups displayed a severe pain response but one regulated to 
moderate pain and stayed regulated, while the other completely regulated at 1 minute but 
then severely dysregulated by 2 minutes. The overall mean represented the immediate 
pain reactivity of most groups of infants well (94% of the sample). However, at 1- and 2-
minutes, the overall mean did not represent the group means well with notable 
underestimations and overestimations of between 1 and 3 MBPS points, misrepresenting 
the entire sample (100%) at least at one (most often at both) of the two epochs that were 
distal to the needle (1-minute and 2-minute epochs).  
The current work strongly suggests that using an overall mean to represent infant 
pain responses distal to the needle (i.e. 1 to 2 minutes out) will lead to clinically 
significant, and sometimes quite severe, misrepresentations of stable subgroups within 
the population of healthy infants. This bias appears to impact much fewer infants at 2 and 
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4 months (6 to 10%), while at 6 and 12 months, the misrepresentation of the overall mean 
was seen with groups making 100% of the sample during the distal post-needle phases. 
However, given the vast majority of infants react severely after a needle poke, the overall 
mean of immediate pain reactivity right after needle was quite representative of both 
younger and older infants, with minor exceptions. Finding indicators that researchers can 
use to account for naturally occurring infant variability in distress expression in between-
group analyses is paramount to understanding how to manage infant pain appropriately. 
Moreover, trying to discern the reasons for this between-group variability (e.g family 
rearing practices, varying pain thresholds, varying predispositions towards negative affect 
regulation, cultural beliefs about pain responding) will also be an important line of 
research.  Another area of variability in healthy infant pain responding that still needs to 
be investigated is within-infant variability.  As recent research with ill/premature infants 
has noted, there is significant within-infant variability in pain responses over a set of 
acutely painful procedures
27,28 
.  Thus, it remains to be seen how the juxtapostion of both 
within-infant and between-infant variability factors into the validity of our current infant 
pain assessment practices.  
Clinically, for the first time, medical professionals are provided with normative 
data regarding how infants respond to acute procedural pain using the most commonly 
utilized painful procedure in general practice (needle pain). It is important to note that in 
our naturalistic context, almost none of the younger infants regulated to low pain levels 
by two minutes, while about 42% of 6-month olds and 52% of 12-month olds regulated to 
mild pain by two minutes. This result suggests that medical professionals who administer 
painful procedures to infants should try to emphasize to families the basic infant mental 
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health principle that infants need a primary caregiver to proximally soothe them during 
painful procedures and help parents find more optimal ways to soothe their infants. In our 
naturalistic study (i.e. parents did what they wanted to do), infants who were still crying 2 
minutes after an immunization were not difficult, they were typical. The current findings 
substantiates the need for not only more research on strategies to manage acute pain but 
also the need for better ways to operationalize the infant pain experience in medical 
practice. 
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Figure 1. Model 1: Latent Groups for Immediate Pain Reactivity at 2, 4, 6, and 12 months 
of age 
 
 
Figure 2. Model 2: Latent Groups for 2 month old Pain Regulation Trajectory 
 
 
 
Figure 3. Model 3: Latent Groups for 4 month old Pain Regulation Trajectory 
 
 
 
 
Figure 4. Model 4: Latent Groups for 6 month old Pain Regulation Trajectory 
 
 
 
 
Figure 5. Model 5: Latent Groups for 12 month old Pain Regulation Trajectory 
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25 word summary: 
Stable variability in infant pain responses increases with age challenging the validity of 
using a mean infant pain score in pain research. 
 
 
*Summary
Figure 1. Model 1: Latent Groups for Immediate Pain Reactivity at 2, 4, 6, and 12 months 
of age 
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Figure 2. Model 2: Latent Groups for 2 month old Pain Regulation Trajectory 
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Figure 3. Model 3: Latent Groups for 4 month old Pain Regulation Trajectory 
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Figure 4. Model 4: Latent Groups for 6 month old Pain Regulation Trajectory 
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Figure 5. Model 5:  Latent Groups for 12 month old Pain Regulation Trajectory 
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Table 1. Demographic Variables 
Variable Total 
Sample 
(n = 747) 
2 month 
Recruitment 
(n = 491) 
4 month 
Recruitment 
(n = 187) 
6 month 
Recruitment 
(n = 69) 
Parental Age at 
Recruitment in Years 
Mean (SD) 
33.5 (5.6) 33.6 (5.0) 33.8 (7.0) 32.6 (5.6) 
Primary Caregiver Education (%) 
Graduate School or 
Professional Training  
30.6 29.8 33.8 28.4 
University graduate 39.8 41.6 37.4 32.8 
Partial university 4.8 4.9 5.3 2.9 
Trade School or 
Community College 
16.8 16.0 15.5 25.4 
High school graduate 7.3 7.1 7.0 9.0 
Some high school 0.5 0.4 0.5 1.5 
Junior high score 
graduate 
0.1 - 0.5 - 
Less than 7
th
 grade 0.1 0.2 - - 
Infant Sex (%) 
    
Male 49.3 50.1 46.0 52.2 
Female 50.7 49.9 54.0 47.8 
Number of Siblings (%) 
    
0 56.2 57.2 55.1 52.2 
1 33.5 33.2 32.1 39.1 
2 8.0 7.0 11.2 7.2 
3 2.0 2.2 1.6 1.5 
4 0.3 0.4 0 0 
Basic Pregnancy Risk 
Factors* (%) 
    
0 62.6 62.7 63.6 58.8 
1-3 37.4 37.3 36.4 41.2 
Note: No infants were recruited at 12 months of age.  
* Basic Pregnancy risk factors (maternal prenatal medication use, cigarette exposure, and 
alcohol and drug exposure) 
 
Table1
Table 2. Model 1: Between Group Comparisons of 2 Latent Groups on Immediate Pain 
Reactivity  (MBPS0) 
 2 months 
M (SD) 
4 months 
M (SD) 
6 months 
M (SD) 
12 months 
M (SD) 
Group 1 8.75 (0.45)
 a
 7.69 (2.02)
 a
 8.06 (1.11)
 a
 3.89 (1.24)
a
 
Group 2 8.82 (0.77)
 a
 8.57 (0.85)
 a
 8.40 (1.11)
 a
 8.53  (0.64)
b
 
t(df) 
p value 
-0.29 (465) 
.77 
-1.73 (15.16)* 
.10 
-1.31 (538) 
.19 
-16.16 (18.42)* 
< .001 
 
     
Overall 
MBPS0 Means 
(Entire Sample 
for Each Age) 
8.80 (0.76) 8.46 (1.01) 8.34 (1.18) 8.27 (1.19) 
NOTE: *Welch’s correction applied due to heterogeneity of variance; Different superscripts within each 
age column indicate significantly different means; Only infants that had a probability of .9 or greater of 
belonging to a particular group were included in Group Means. All infants at a particular age were included 
in overall means.  See Figure 1 for graphic depiction of means.  
Table2
Table 3. Models 2-5: Mean Pain Scores of the Latent Groups at 2, 4, 6, and 12 months over the 
Immunization Appointment (MBPS 0, MBPS1 and MBPS2) 
 Immediately post-
needle 
MBPS0 Mean (SD) 
1-minute post-
needle 
MBPS1 Mean (SD) 
2-minutes post-
needle 
MBPS2 Mean (SD) 
2 months (Model 2) 
   
Group 1 7.85 (0.45)
 a
 5.05 (2.51)
 a
 4.96 (2.62)
a
 
Group 2 9.07 (0.26)
 a
 6.46 (2.25)
 a
 5.83(2.50)
 a
 
t(df) 
p value 
-24.45 (97.52)* 
 < .001 
-4.54 (103.00)* 
< .001 
-2.62 (419) 
.009 
Overall Mean 8.81 (0.76) 6.18 (2.37) 5.65 (2.55) 
    
4 months (Model 3) 
   
Group 1 6.80 (0.57)
 a
 2.46 (1.45)
 a
 3.00 (1.93)
 a
 
Group 3 8.20 (0.40)
 b
 4.92 (2.47)
 b
 4.62 (2.53)
 b
 
Group 4 9.08 (0.26)
 c
 5.32 (2.46)
 b
 5.07 (2.57)
 b
 
F (df) 
p value 
1031.03 (2, 548)* 
< .001 
30.38 (2, 520)* 
< .001 
14.45 (2, 506)* 
< .001 
Overall Mean 8.46 (1.01) 4.86 (2.52) 4.70 (2.58) 
    
6 months (Model 4) 
   
Group 1 8.41 (0.72)
 a
 3.89 (2.30)
 a
 2.25 (0.66)
 a
 
Group 2 8.73 (0.76)
 b
 6.01 (2.38)
 b
 7.23 (1.18)
 b
 
Group 3 4.00 (1.33)
 c
 2.11 (0.74)
 c
 2.21 (0.98)
 a
 
F(df) 
p value 
329.41 (2, 482)* 
< .001 
60.12 (2, 471)* 
< .001 
1669.77 (2, 476)* 
< .001 
Overall Mean 8.34 (1.18) 4.78 (2.58) 4.32 (2.60) 
    
12 months (Model 
5) 
   
Group 1 3.89 (1.24)
 a
 2.37 (1.01)
a
 2.28 (1.60)
a
 
Group 2 8.70 (0.61) )
b
 7.80 (0.79)
b
 7.52 (1.00)
b
 
Group 3 8.37 (0.59)
 b
 6.92 (1.02)
c
 2.34 (0.67)
a
 
Group 4 8.26 (0.68)
 b
 2.26 (0.64)
a
 2.08 (0.51)
a
 
Group 5 8.40 (0.60)
 b
 2.15 (0.49)
a
 7.05 (0.94)
b
 
Group 6 9.00 (0.00)
c
 4.50 (0.55)
d
 5.17 (0.75)
c
 
F(df) 
p value 
176.44 (5, 337)* 
< .001 
655.83 (5, 338)* 
< .001 
573.28 (5, 331)* 
< .001 
Overall Mean 8.27 (1.20) 5.61 (2.49) 4.80 (2.59) 
NOTE: *Correction applied due to heterogeneity of variance for post-hoc tests following the significant 
omnibus test. Different subscripts denote significantly different means (p < .006) within each of the 12 age-
epoch ANOVA analyses; Only infants that had a probability of >.9 or greater of belonging to a particular 
group were included in Group Means. All infants within an age-epoch combination were included in 
overall means. Only groups with proportions greater than 5% of the whole sample are included in Table 3. 
See Figures 2-5 for graphic depiction of group means.  
Table3
